Novo Nordisk's Wegovy wins EU backing for reducing heart risks
July 26, 2024 at 06:07 AM EDT
Novo Nordisk's Wegovy has received backing from the EU's medical regulator to expand the weight loss drug's use to reducing the rise of serious heart events.
